These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

498 related items for PubMed ID: 18056168

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Wnt3 gene expression promotes tumor progression in non-small cell lung cancer.
    Nakashima N, Liu D, Huang CL, Ueno M, Zhang X, Yokomise H.
    Lung Cancer; 2012 May; 76(2):228-34. PubMed ID: 22070884
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Wnt1 overexpression associated with tumor proliferation and a poor prognosis in non-small cell lung cancer patients.
    Nakashima T, Liu D, Nakano J, Ishikawa S, Yokomise H, Ueno M, Kadota K, Huang CL.
    Oncol Rep; 2008 Jan; 19(1):203-9. PubMed ID: 18097596
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH, Wang SF, Yu L, Wang J, Chang H, Yan WL, Zhang J, Fu K.
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [Abstract] [Full Text] [Related]

  • 11. Significance of thymidylate synthase gene expression level in patients with adenocarcinoma of the lung.
    Hashimoto H, Ozeki Y, Sato M, Obara K, Matsutani N, Nakagishi Y, Ogata T, Maehara T.
    Cancer; 2006 Apr 01; 106(7):1595-601. PubMed ID: 16489621
    [Abstract] [Full Text] [Related]

  • 12. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.
    Zhang Z, Ma J, Li N, Sun N, Wang C.
    Ann Thorac Surg; 2006 Jul 01; 82(1):243-8. PubMed ID: 16798222
    [Abstract] [Full Text] [Related]

  • 13. Telomerase activity and expression of the telomerase catalytic subunit gene in non-small cell lung cancer: correlation with decreased apoptosis and clinical prognosis.
    Wang J, Liu X, Jiang W, Liang L.
    Chin Med J (Engl); 2000 Nov 01; 113(11):985-90. PubMed ID: 11776132
    [Abstract] [Full Text] [Related]

  • 14. Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer.
    Tanabe H, Yagihashi A, Tsuji N, Shijubo Y, Abe S, Watanabe N.
    Lung Cancer; 2004 Dec 01; 46(3):299-304. PubMed ID: 15541814
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer.
    Liu D, Nakano J, Ishikawa S, Yokomise H, Ueno M, Kadota K, Urushihara M, Huang CL.
    Lung Cancer; 2007 Dec 01; 58(3):384-91. PubMed ID: 17728005
    [Abstract] [Full Text] [Related]

  • 16. Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer.
    Bria E, Visca P, Novelli F, Casini B, Diodoro MG, Perrone-Donnorso R, Botti C, Sperduti I, Facciolo F, Milella M, Cecere FL, Cognetti F, Mottolese M.
    Eur J Surg Oncol; 2008 May 01; 34(5):593-8. PubMed ID: 17693049
    [Abstract] [Full Text] [Related]

  • 17. Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer.
    Tsubochi H, Sato N, Hiyama M, Kaimori M, Endo S, Sohara Y, Imai T.
    Ann Thorac Surg; 2006 Oct 01; 82(4):1198-204. PubMed ID: 16996907
    [Abstract] [Full Text] [Related]

  • 18. [Expression and mutation of Fas-associated death domain (FADD) gene in non-small cell lung cancer].
    Yang Q, Zhu RQ, Fang Z, Xia D, Diao LM, Liu MQ.
    Ai Zheng; 2005 Mar 01; 24(3):321-6. PubMed ID: 15757534
    [Abstract] [Full Text] [Related]

  • 19. Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (tegafur+uracil) in patients with non-small cell lung cancer.
    Miyoshi T, Kondo K, Toba H, Yoshida M, Fujino H, Kenzaki K, Sakiyama S, Takehisa M, Tangoku A.
    Anticancer Res; 2007 Mar 01; 27(4C):2641-8. PubMed ID: 17695427
    [Abstract] [Full Text] [Related]

  • 20. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J.
    Lung Cancer; 2009 Mar 01; 63(3):410-7. PubMed ID: 18620780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.